Super Cocktail Kills Breast Cancer Cells

“You cannot poison yourself into health. This is a law.” ~ Dr. Charles Majors, co-author, The Cancer Killers

 

Dr. Shailaja G.  Raj, a gynecologist and reproductive endocrinology and fertility expert with a clinical practice in the greater New Orleans area, knows that for many women their greatest fear is getting breast cancer. That’s why no one could be more excited about research results published in the November 2013 Journal of Cancer – regarding a cocktail of plant compounds that killed breast cancer cells in the laboratory – unless it is her husband, Madhwa H.G. Raj PhD, who led the study in collaboration with the Louisiana State University (LSU) Health Sciences Center and its Stanley S. Scott Cancer Center. “The ingredients in the cocktail come from foods people eat everyday, but at much higher levels than they could possibly get from their diet,” says Madhwa Raj, a research professor in Obstetrics and Gynecology at LSU’s Health Sciences Center.

What the research showed was that a combination of six known protective chemical nutrients from turmeric, soybeans, broccoli, grapes and tea were more effective against cancer cells in vitro than each would be individually. Individually they were ineffective, but in combination these natural compounds killed 100% of the sample breast cancer cells without toxic side-effects to normal cells. The researchers tested other known protective ingredients found in apples and tofu but eventually settled on the combination of the six that suppressed breast cancer cell growth by more than 80%. The resulting super-cocktail – curcumin, known as turmeric, isoflavone from soybeans, indo-3-cabinol from cruciferous plants, C-phycocyanin from spirulina, reservatrol from grapes and quercetin, a flavonoid present in fruits, vegetables, and tea also inhibited migration and invasion of cancer cells, caused cycle arrest, and triggered the process leading to cell death resulting in the death of 100% of the breast cancer cells in the samples.

Madhwa Raj adds that the super anti-oxidant combination also inhibited a marker protein for metastisis and that there is nothing else in the drug realm available that has been shown to do that.  “One of the primary causes of both the recurrence of breast cancer and deaths is a small group of cancer stem cells that evade therapy. These often multi-drug-resistant cells have the ability to generate new tumors, so it is critically important to develop new approaches to more effective and safer treatment or prevention of breast cancer,” notes Raj, who has served as reviewer for many medical journals including Endocrinology, International Journal of Cancer, Breast Cancer Research and others.

When the research was published, the researchers received many emails from around the globe requesting where they could get this super-cocktail.

It was Shailaja Raj who decided to develop a supplement to make it available now. She explains that she decided to do this, because she believes that its super anti-oxidant properties may be helpful to women now as a nutritional supplement for breast health. “The combination has been shown to work in vitro, so there is a scientific basis for the product. I have confidence that it is a good product, since we were a part of it. This combination is not available anywhere else and is a pure compound.” She is collaborating with Protegene Corporation in the development of this nutritional supplement, which is available at ProtegeneCorporation.com

She emphasizes that the supplement cannot be considered a treatment for breast cancer, nor a preventive treatment until clinical trials actually determine that.  As for recommending the supplement to her own patients, she says she doesn’t push it. As she does with other medications and products, she gives her patients information and let’s them decide.

According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program (SEER), which includes data from LSU Health Sciences Center New Orleans, breast cancer is the second most common cancer with 232,340 new cases estimated this year and 39,620 deaths. There are an estimated 2,829,041 women currently living with breast cancer in the United States.